Programs
Let Us Help You By Making An Appointment
Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HOCM) is an autosomal dominant disorder characterized by unexplained increased muscle thickness of the left ventricle and disorganized cardiac cells and scarring. It is the most common heritable cardiovascular disorder with an estimated prevalence of 1/1000 in the general population.
Although most individuals with HCM do well with appropriate treatment, this condition can be associated with an increased risk for progressive heart failure and sudden death.
How Our Program Works
An integrative approach is essential for optimal management of patients and families with hypertrophic cardiomyopathy, with particular attention to unique features of this disorder. Our multidisciplinary clinic provides: Individualized care plans, genotypic analysis for definitive diagnosis, comprehensive evaluation of affected individuals (cardiac imaging, stress testing, surveillance for heart rhythm disturbances), HOCM family screening, stratification regarding risk for sudden cardiac death, implantable cardioverter defibrillator and pacemaker therapy, alcohol septal ablation or surgical septal myectomy for refractory symptoms, and management of end-stage heart failure, including cardiac transplantation.
For more information about CANM’s Hypertrophic Cardiomyopathy Program, please call 662-620-6800.